Contrast

Contact

Share

MyChart

Help

Awards, Achievements, & Innovations

Smilow Cancer Hospital has been at the forefront of many medical advances for treating cancer in Connecticut, nationally and around the world.

Awards

Quality Oncology Practice Initiative

Quality Oncology Practice Initiative (QOPI®) Certification

Smilow Cancer Hospital is recognized by the American Society of Clinical Oncology with QOPI certification. Achieving QOPI status recognizes that Smilow outpatient hematology-oncology practices deliver the highest quality in patient care and safety for patients receiving chemotherapy.
APex

Radiation Oncology Program for Excellence

First in Connecticut and adjacent states to be awarded accreditation by the American Society for Radiation Oncology Accreditation Program for Excellence (APEx) for Smilow Cancer Hospital sites in New Haven, Hamden, Guilford, Trumbull and Waterford. This accreditation ensures that patients who choose Smilow Cancer Hospital for their radiation oncology treatment receive care delivered with the highest safety and quality standards in the industry.

Achievements and Innovations

  • Yale Cancer Center is Connecticut’s only comprehensive cancer center, designated by the National Cancer Institute in 1974
  • Connecticut’s largest provider of cancer care – treating more than 48% of the 20,000 patients diagnosed with cancer annually in the state
  • The only comprehensive cancer facility in the Northeast, bringing together both inpatient and outpatient care in one hospital
  • First in the nation to install and use the 3 Tesla MRI neuro suite by IMRIS for brain cancer treatment
  • More than 300 clinical trials, including Phase I chemotherapy trials
  • Performs the most endoscopic ultrasounds (EUS) in Connecticut
  • A member of the National Comprehensive Cancer Network (NCCN)
  • Recognized by the National Pancreas Foundation as a Center of Excellence where surgeons specialize in and treat pancreatic cancers
  • The Center for Community Engagement and Health Equity (CEHE) exists within Smilow Cancer Hospital and Yale Cancer Center with a mission of ensuring cancer health equity and improving outcomes especially in traditionally marginalized communities.

A History of Innovation

In the history of cancer treatment, Yale School of Medicine is perhaps best known as the institution where cancer chemotherapy and the entire field of cancer drug development was discovered and the very first cancer drug was administered in 1942. The legacy continues through Yale Cancer Center, the collaboration of Smilow Cancer Hospital, Yale University and Yale Medicine.